Oral bisphosphonates reduce the risk of clinical fractures in glucocorticoid-induced osteoporosis in clinical practice

被引:0
|
作者
T. Thomas
S. Horlait
J. D. Ringe
A. Abelson
D. T. Gold
P. Atlan
J. L. Lange
机构
[1] University Hospital of Saint-Etienne,INSERM U1059, Rheumatology Department
[2] Warner Chilcott,Medizinische Klinik IV (Osteology, Rheumatology), Klinikum Leverkusen
[3] University of Cologne,undefined
[4] Cleveland Clinic Foundation,undefined
[5] Duke University Medical Center,undefined
[6] Procter & Gamble,undefined
来源
Osteoporosis International | 2013年 / 24卷
关键词
Bisphosphonates; Clinical fractures; Glucocorticoid-induced osteoporosis; Risk reduction;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:263 / 269
页数:6
相关论文
共 50 条
  • [31] The Efficacy of Minodronate in the Treatment of Glucocorticoid-induced Osteoporosis
    Hasegawa, Eriko
    Ito, Satoshi
    Takai, Chinatsu
    Kobayashi, Daisuke
    Nomura, Yumi
    Otani, Hiroshi
    Abe, Asami
    Ishikawa, Hajime
    Murasawa, Akira
    Narita, Ichiei
    Nakazono, Kiyoshi
    INTERNAL MEDICINE, 2018, 57 (15) : 2169 - 2178
  • [32] Bisphosphonate use for glucocorticoid-induced osteoporosis in older patients with immune thrombocytopenia: a clinical perspective
    Yamasaki, Satoshi
    ANNALS OF HEMATOLOGY, 2023, 102 (07) : 1645 - 1656
  • [33] Bisphosphonate use for glucocorticoid-induced osteoporosis in older patients with immune thrombocytopenia: a clinical perspective
    Satoshi Yamasaki
    Annals of Hematology, 2023, 102 : 1645 - 1656
  • [34] Glucocorticoid-induced osteoporosis: Prevention and treatment
    Ziegler, R
    Kasperk, C
    STEROIDS, 1998, 63 (5-6) : 344 - 348
  • [35] Bone ultrasonography in glucocorticoid-induced osteoporosis
    C. Cepollaro
    S. Gonnelli
    P. Rottoli
    A. Montagnani
    C. Caffarelli
    D. Bruni
    N. Nikiforakis
    A. Fossi
    S. Rossi
    R. Nuti
    Osteoporosis International, 2005, 16 : 743 - 748
  • [36] Histomorphometric analysis of glucocorticoid-induced osteoporosis
    Carbonare, LD
    Bertoldo, F
    Valenti, MT
    Zenari, S
    Zanatta, M
    Sella, S
    Giannini, S
    Lo Cascio, V
    MICRON, 2005, 36 (7-8) : 645 - 652
  • [37] Glucocorticoid-induced osteoporosis: pathogenesis and management
    Nishimura, J
    Ikuyama, S
    JOURNAL OF BONE AND MINERAL METABOLISM, 2000, 18 (06) : 350 - 352
  • [39] Prevention and treatment of glucocorticoid-induced osteoporosis
    Eggelmeijer, F
    PHARMACY WORLD & SCIENCE, 1998, 20 (05): : 193 - 197
  • [40] Glucocorticoid-induced osteoporosis: hope on the HORIZON
    Gennari, Luigi
    Bilezikian, John P.
    LANCET, 2009, 373 (9671) : 1225 - 1226